Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study-Reference-Cited by-同舟云学术

Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study

Published:2021-06-25 Issue:4 Volume:39 Page:498-505
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Akay Olga Meltem¹^ORCID,Ozbalak Murat²^ORCID,Pehlivan Mustafa³^ORCID,Yildiz Birol⁴,Uzay Ant⁵^ORCID,Yigenoglu Tugce Nur⁶^ORCID,Elverdi Tugrul⁷^ORCID,Kaynar Leylagul⁸^ORCID,Ayyildiz Orhan⁹,Yonal Hindilerden Ipek²^ORCID,Goksoy Hasan Sami¹⁰,Izmir Guner Sebnem¹¹^ORCID,Gunes Ahmet Kursad¹²^ORCID,Sonmez Mehmet¹³,Kurt Yuksel Meltem¹⁴^ORCID,Civriz Bozdag Sinem¹⁴^ORCID,Ozkurt Zubeyde Nur¹⁵^ORCID,Toptas Tayfur¹⁶^ORCID,Dogu Mehmet Hilmi¹⁷^ORCID,Salim Ozan¹⁸,Saydam Guray¹⁹^ORCID,Yavasoglu Irfan²⁰^ORCID,Ayli Meltem⁴^ORCID,Ozet Gulsum²¹,Albayrak Murat²²^ORCID,Birtas Atesoglu Elif²³^ORCID,Toprak Selami K.¹⁴^ORCID,Yildirim Rahsan²⁴,Mehtap Ozgur²⁵^ORCID,Kalayoglu Besisik Sevgi²^ORCID,Nalcaci Meliha²^ORCID,Altuntas Fevzi⁶,Ferhanoglu Burhan¹²⁶^ORCID

Affiliation:

1. Department of Internal Medicine Division of Hematology Koç University Medical Faculty Istanbul Turkey

2. Department of Internal Medicine Division of Hematology Istanbul Medical Faculty Istanbul University Istanbul Turkey

3. Department of Internal Medicine Division of Hematology Gaziantep University Medical Faculty Gaziantep Turkey

4. Department of Internal Medicine Division of Medical Oncology Gulhane Research and Training Hospital Ankara Turkey

5. Depatment of Hematology Acıbadem University Medical Faculty Istanbul Turkey

6. Division of Hematology Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital Ankara Turkey

7. Department of Internal Medicine Division of Hematology Istanbul University Cerrahpaşa Medical Faculty Istanbul Turkey

8. Department of Internal Medicine Division of Hematology Erciyes University Medical Faculty Kayseri Turkey

9. Department of Internal Medicine Division of Hematology Dicle University Medical Faculty Diyarbakır Turkey

10. Depatment of Hematology Yeniyuzyıl University Gaziosmanpaşa Hospital Istanbul Turkey

11. Depatment of Hematology Memorial Şişli Hospital Istanbul Turkey

12. Depatment of Hematology Mehmet Akif İnan Hospital Şanlıurfa Turkey

13. Department of Internal Medicine Division of Hematology Karadeniz Technical University Trabzon Turkey

14. Department of Internal Medicine Division of Hematology Ankara University Medical Faculty Ankara Turkey

15. Department of Internal Medicine Division of Hematology Gazi University Medical Faculty Ankara Turkey

16. Department of Internal Medicine Division of Hematology Marmara University Medical Faculty Istanbul Turkey

17. Division of Hematology Istanbul Research and Training Hospital Istanbul Turkey

18. Department of Internal Medicine Division of Hematology Akdeniz University Medical Faculty Antalya Turkey

19. Department of Internal Medicine Division of Hematology Ege University Medical Faculty Izmir Turkey

20. Department of Internal Medicine Division of Hematology Adnan Menderes University Medical Faculty Aydın Turkey

21. Division of Hematology Ankara City Hospital Ankara Turkey

22. Division of Hematology Dışkapı Research and Training Hospital Ankara Turkey

23. Division of Hematology Anadolu Medical Center Izmıt Turkey

24. Department of Internal Medicine Division of Hematology Ataturk University Medical Faculty Erzurum Turkey

25. Department of Internal Medicine Division of Hematology Kocaeli University Medical Faculty İzmit Turkey

26. Division of Hematology V.K.V. American Hospital İstanbul Turkey

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2897

Reference26 articles.

1. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

2. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients from the French registry

3. A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

4. Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse

5. Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody based therapies in Hodgkin lymphoma;Cancer Treatment Reviews;2024-01

2. Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability;Oncotarget;2023-12-12

3. Sequencing novel agents in the treatment of classical Hodgkin lymphoma;Expert Review of Hematology;2023-11-16

4. Brentuximab vedotin consolidation therapy after autologous stem cell transplantation in relapsed/refractory classic Hodgkin lymphoma patients in the Czech Republic;Onkologie;2023-10-05

5. Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary;Annals of Hematology;2023-07-10